Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

Depression and Suicide Risk in Children and Adolescents: Screening

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: October 2022

The U.S. Preventive Services Task Force (USPSTF) recommends screening for major depressive disorder (MDD) in adolescents ages 12 to 18 years and who are not showing recognized signs or symptoms of depression. Depression is a leading cause of disability in the U.S. Children and adolescents with depression often have functional impairments in their performance at school or work, as well as in their interactions with their families and peers. Depression can negatively affect development in affected youth. USPSTF found insufficient evidence to assess whether the benefits outweigh the harms in screening for MDD in children age 11 years and younger — and screening for suicide risk in children and adolescents.

Read more about this resource

Objectives related to this resource (3)

Suggested Citation

1.

U.S. Preventive Services Task Force. (2022). Depression and Suicide Risk in Children and Adolescents: Screening. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents.